TrialCell reports. Medicine2025

Sintilimab plus chemotherapy for first-line treatment of advanced pulmonary lymphoepithelioma-like carcinoma: Phase 2 trial.

Xinqing Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.